Related Experiment Videos
Managing diabetes in the elderly: go easy, individualize.
1Division of Geriatrics, Department of Medicine, Case Western Reserve University School of Medicine, OH, USA.
Cleveland Clinic Journal of Medicine
|February 2, 2008
Summary
Individualized diabetes care for seniors is crucial, prioritizing quality of life over strict glycemic control, especially for frail elderly patients. Focus on preventing malnutrition and hypoglycemia to improve well-being.
Area of Science:
- Geriatrics
- Endocrinology
- Internal Medicine
Background:
- Diabetes mellitus is a prevalent chronic condition in the elderly population.
- Aging presents unique physiological challenges that impact diabetes management.
- Comorbidities and polypharmacy are common in older adults with diabetes.
Purpose of the Study:
- To emphasize the need for individualized diabetes care in elderly patients.
- To highlight the importance of quality of life over strict glycemic control in frail elderly individuals.
- To guide clinical decision-making for optimizing diabetes management in geriatric populations.
Main Methods:
- This is a review and expert opinion piece, not a clinical trial.
- Key considerations for individualized care were identified through clinical experience and literature review.
- Factors such as comorbidities, medications, cognitive status, and social support were analyzed.
Main Results:
- Strict glycemic control may not be appropriate or achievable for all elderly patients, particularly the frail.
- Avoiding malnutrition and hypoglycemia is paramount in frail elderly individuals with diabetes.
- Prioritizing quality of life and functional independence is a key outcome.
Conclusions:
- Diabetes management in the elderly requires a personalized approach tailored to individual circumstances.
- For frail elderly patients, the goals of care should shift from strict glycemic targets to maintaining nutritional status, preventing hypoglycemia, and enhancing quality of life.
- A multidisciplinary approach involving healthcare providers, caregivers, and the patient is essential for effective diabetes care in older adults.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...